Our continuous perfusion bioreactor systems are specially engineered for high-efficiency monoclonal antibody (mAb) production. Adopting advanced cell retention technology, the systems enable uninterrupted medium exchange while retaining viable cells inside the vessel, achieving ultra-high cell density and prolonged culture duration.
Optimized fluid dynamics and low-shear design protect delicate mammalian cells throughout long-term perfusion runs. Precise closed-loop control over temperature, pH, dissolved oxygen and flow rates maintains a stable culture environment, delivering consistent product quality and drastically boosting volumetric productivity compared to traditional batch and fed-batch processes.
Fully integrated with automated sampling, separation and monitoring units, the platform simplifies operation and reduces manual intervention. Compatible with GMP production requirements, it supports seamless scale-up from pilot to commercial manufacturing. It is a premium solution to cut production costs, shorten production cycles and maximize output for monoclonal antibody manufacturing.
